RxDoctor Payments Data

Edward Schloss, MD

Clinical Cardiac Electrophysiology · Cincinnati, OHNPI 1972567964

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $12,228 and has fallen 73.9% since, to $3,197 in 2025.

$33,641in general payments, 2019–2025

Across 133 payments — averaging $252.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$25K
  • Boston Scientific$8K
  • AOP Health US, LLC$306
  • Atricure, Inc.$216
  • Cardiva Medical, Inc.$83
  • Abbott$83
  • plus $126 from 4 others
$63,017in research payments, 2019–2025

Across 43 payments — averaging $1465.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$61K
  • Boston Scientific$2K

What the payments were for

  • Consulting fees$17,02551%
  • Speaking & faculty fees$7,20021%
  • Travel & lodging$5,11015%
  • Food & beverage$4,30613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)92$25,188
Boston Scientific22$7,641
AOP Health US, LLC1$306
Atricure, Inc.5$216
Cardiva Medical, Inc.3$83
Abbott4$83
Bardy Diagnostics, Inc.2$50
Elutia, Inc.2$26
Biosense Webster, Inc.1$25
Boehringer Ingelheim1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,641 in reported general payments places this provider in the 65th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$420,768
Medicare patients
900
Services billed
8,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban308$293,829
XareltoRivaroxaban76$85,310
Dofetilide11$5,183
Amiodarone Hcl89$2,415
Metoprolol Succinate227$1,970
SotalolSotalol Hcl63$1,122
Flecainide Acetate32$1,080
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$809
Digoxin20$494
Bisoprolol Fumarate25$335
Metoprolol Tartrate52$293
Warfarin Sodium44$227
Atenolol16$125
Lisinopril24$101
Carvedilol16$60

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →